Reuters logo
BRIEF-Elanix Biotechnologies unit signs agreement to support commercialization of Gynrepair
September 20, 2017 / 6:03 AM / a month ago

BRIEF-Elanix Biotechnologies unit signs agreement to support commercialization of Gynrepair

Sept 20 (Reuters) - ELANIX BIOTECHNOLOGIES AG:

* ELANIX BIOTECHNOLOGIES SUBSIDIARY SIGNS WHOLESALE & LOGISTICS AGREEMENT IN EUROPE TO SUPPORT EXPANDING COMMERCIALIZATION OF GYNREPAIR Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below